doi: 10.1111/cts.13270.
Epub 2022 Mar 25.
The economics of moonshots: Value in rare disease drug development
Affiliations
- PMID: 35334152
- PMCID: PMC9010265
- DOI: 10.1111/cts.13270
Item in Clipboard
The economics of moonshots: Value in rare disease drug development
Clin Transl Sci.
2022 Apr.
No abstract available
Conflict of interest statement
The authors declared no competing interests for this work.
Similar articles
-
Patients left behind: Rare dermatologic conditions miss the orphan drug development boom.J Am Acad Dermatol. 2019 Oct;81(4):1025-1026. doi: 10.1016/j.jaad.2019.03.013. Epub 2019 Mar 14. J Am Acad Dermatol. 2019. PMID: 30880063 No abstract available.
-
A decade of optimizing drug development for rare neuromuscular disorders through TACT.Nat Rev Drug Discov. 2020 Jan;19(1):1-2. doi: 10.1038/d41573-019-00199-1. Nat Rev Drug Discov. 2020. PMID: 31907422 No abstract available.
-
Orphan drug development in China: progress and challenges.Lancet. 2019 Sep 28;394(10204):1127-1128. doi: 10.1016/S0140-6736(19)32179-8. Lancet. 2019. PMID: 31571591 No abstract available.
-
Case studies in rare disease small molecule discovery and development.Bioorg Med Chem Lett. 2020 Nov 1;30(21):127462. doi: 10.1016/j.bmcl.2020.127462. Epub 2020 Aug 11. Bioorg Med Chem Lett. 2020. PMID: 32791196 Review.
-
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.Nat Rev Drug Discov. 2020 Feb;19(2):93-111. doi: 10.1038/s41573-019-0049-9. Epub 2019 Dec 13. Nat Rev Drug Discov. 2020. PMID: 31836861 Review.
Cited by
-
Application of observational research methods to real-world studies for rare disease drugs: A scoping review protocol.PLoS One. 2025 Mar 28;20(3):e0304540. doi: 10.1371/journal.pone.0304540. eCollection 2025. PLoS One. 2025. PMID: 40153394 Free PMC article.
-
CASCADE: a community-engaged action model for generating rapid, patient-engaged decisions in clinical research.BMC Med Res Methodol. 2025 Jul 1;25(1):168. doi: 10.1186/s12874-025-02565-7. BMC Med Res Methodol. 2025. PMID: 40597746 Free PMC article.
-
Rarer dementias, limited options, and unaddressed needs.Int Psychogeriatr. 2024 Jun;36(6):451-454. doi: 10.1017/S1041610223000431. Epub 2023 May 4. Int Psychogeriatr. 2024. PMID: 37137670 Free PMC article. No abstract available.
-
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.Front Oncol. 2023 Dec 7;13:1250766. doi: 10.3389/fonc.2023.1250766. eCollection 2023. Front Oncol. 2023. PMID: 38130992 Free PMC article. Review.
-
Economic Burden of Sanfilippo Syndrome in the United States.Res Sq [Preprint]. 2023 Nov 1:rs.3.rs-3001450. doi: 10.21203/rs.3.rs-3001450/v4. Res Sq. 2023. PMID: 37398464 Free PMC article. Preprint.
References
-
- Richter T, Nestler‐Parr S, Babela R, et al. Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18:906‐914. - PubMed
-
- Bagley N, Berger B, Chandra A, Garthwaite C, Stern AD. The Orphan Drug Act at 35: observations and an outlook for the twenty‐first century. Innov Policy Econ. 2019;19:97‐137.
-
- Sarpatwari A, Beall RF, Abdurrob A, He M, Kesselheim AS. Evaluating the impact of the Orphan Drug Act’s seven‐year market exclusivity period. Health Aff. 2018;37:732‐737. - PubMed
-
- Nabhan C, Phillips EG Jr, Feinberg BA. Orphan cancer drugs in the era of precision medicine. JAMA Oncol. 2018;4:1481‐1482. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
